PRINCETON, N.J.--(BUSINESS WIRE)--PharmaNet Development Group, Inc. (NASDAQ: PDGI), a leading provider of drug development services, announces that Mark Di Ianni has been appointed president, early stage development. Mr. Di Ianni’s new role will include responsibility for the Company’s early stage clinical development business. He will retain the position of executive vice president, strategic initiatives.
